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1. Introduction 
Glycine is probably a major inhibitory transmitter 
in the mammalian central nervous system [ 1,2] . 
Hence the metabolism and metabolic control of 
glycine could be important for the efficient function- 
ing of nervous tissue, particularly of the spinal cord. 
As glycine may be formed from serine by serine 
hydroxymethylase (EC 2.1.2.1) [3] , enzymes neces- 
sary for the formation of serine from carbohydrate 
sources could be important for the production and 
regulation of glycine. Two major pathways of serine 
formation have been described in mammalian sys- 
tems, the “phosphoryl:ted” pathway from 3-phos- 
phoglycerate [4], and the “non-phosphorylated” 
pathway from D-glycerate [5,6]. We decided there- 
fore to determine if glycine has any effect on either 
D(-)3-phosphoglycerate:NAD oxidoreductase 
(3-phosphoglycerate dehydrogenase) or D-glycerate: 
NAD (P) oxidoreductase (EC 1.1.1.29) (D-glycerate 
dehydrogenase). 
The results recorded here show that glycine ap 
pears to inhibit D-glycerate dehydrogenase of rat 
cortex in a manner non-competitive with respect to 
Dglycerate, and to inhibit 3-phosphoglycerate dehy- 
drogenase to a much smaller degree. Limited data for 
serine inhibition indicate that serine probably inhibits 
3-phosphoglycerate dehydrogenase in a non-linear 
fashion, and much more strongly than glycine, and is 
only a poor inhibitor of D-glycerate dehydrogenase. 
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2. Materials and methods 
Barium phosphoglycerate and calcium DL-glycer- 
ate purchased from Sigma Chemical Corporation, were 
converted to sodium salts by passage through a 
column of Dowex-SO(H?) and neutralization of the 
emerging acids. Phosphoglycerate concentration was 
estimated by the method of Czok and Eckert [7]. 
Glycerate was estimated by the method of Bartlett 
[8] with the concentration of chromotrophic acid 
raised to 0.025% as recommended by Dawkins and 
Dickens [9] . NAD was purchased from P-L Biochemi- 
cals, and NADP from Sigma. 
Rat cortical tissue was homogenized in 0.32 M 
sucrose containing 0.5 mM dithiothreitol (DTT) and 
centrifuged at 105,000 g for 100 min. The 20-80% 
ammonium sulphate fraction of the supernatant was 
dissolved in 10 mM potassium phosphate buffer pH 
6.8 with 0.5 mM DTT and EDTA, and dialysed 
against the same buffer until free from ammonium 
sulphate. The precipitate which formed during dialysis 
was removed and the supernatant used for enzyme 
analysis. With this preparation, no breakdown of 
phosphoglycerate or glycerate could be detected in 
the absence of nucleotides under the conditions of 
enzyme measurement. 
The enzyme activities were measured by the method 
of Sallach [lo] , except that tris buffer was replaced 
by tris(hydroxymethyl)methylaminopropane sul- 
phonic acid (TAPS) buffer, glutathione by DTT, and 
Dglycerate dehydrogenase was measured using NADP 
with DL-glycerate. Details are given in the legends to 
the figures. Reaction mixtures were incubated at 30’ 
in a Shimadzu spectrophotometer and the absorbance 
at 3400 A was read at 1 min intervals. Since there was 
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Fig. 1. Double reciprocal plot of the initial velocity of the re 
action catalysed by rat brain D-glycerate dehydrogenase with 
DL-glycerate as variable substrate in the presence and absence 
of glycine or serine. Reaction mixtures contained 100 mM 
TAPS buffer pH 9.0, 167 mM hydrazine sulphate pH 9.0, 
0.4 mM DTT and EDTA, 42 mM NaCl, 0.83 mM NADP, vary- 
ing concentrations of DLglycerate as shown, glycine or serine 
as indicated, and rat brain extract in a total volume of 1.2 
ml. Concentrations of glycine were: l , 0 mM; o, 10 mM; o, 
20 mM; e, 30 mM. Concentrations of serine were: a, 10 mM; 
A, 20 mM. Velocities are expressed as nmoles of NADPH 
formed per min per mg protein. The points are experimental; 
the lines represent he fit to the equation 
v = VA l(K(1 + l/Q + A (1 + l/Ki$] for linear non-compe 
titive inhibition using the computer program of Cleland [ 121. 
Table 1 
Kinetic constants for the inhibition of D-glycerate dehydro 
genase by glycine and serine. The values for Kis and Kii for 
glycine inhibition are weighted means of two experiments. 
The values for weighted mean and standard error were cal- 
culated using the formula given in Morrison and James [ 131. 
Variable 
substrate 
Inhibitor Kis mM Kii mM 
DGlycerate Glycine 13.73 f 1.64 33.84 f 4.61 
Serine 120.7 * 91.3 76.4 c 22.2 
3-Phospho- 
glycerate 
Glycine 35.2 * 9.9 154.9 * 47.0 
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Fig. 2. Analysis of data for the measurement of 3-phospho- 
glycerate dehydrogenase. Velocities are expressed as nmoles 
NADH formed per min per mg protein. (A) Velocity of NADH 
formation in the absence of 3-phosphoglycerate plotted as a 
function of the concentration of glycine (u) or serine (0). Re 
action mixtures contained 100 mM TAPS buffer pH 9.0, 167 
mM hydrazine sulphate pH 9.0,0.4 mM EDTA and DTT, 
0.83 mM NAD, rat cortex extract, and glycine and serine at 
concentrations as indicated, in a final volume of 1.2 ml. (B) 
Double reciprocal plot of initial velocity with 3-phospho- 
glycerate as variable substrate in the presence or absence of 
glycine. Reaction mixtures were as in fig. 2A except that 
3-phosphoglycerate was present at varying concentrations as 
shown. Concentrations of glycine were: n , 0 mM; 0, 10 mM; 
0, 20 mM; o, 30 mM. The points are experimental. The lines 
represent he tit to linear non-competitive inhibition. (C) 
Double reciprocal plot of initial velocity with 3-phospho 
glycerate as variable substrate in the presence and absence of 
serine. The reaction mixtures are as described in fig. 2B ex- 
cept that glycine is replaced by serine at concentrations of: 
A, 0 mM; o, 10 mM; 0, 20 mM. The points are experimental. 
The lines represent he fit of the data for each concentration 
of serine to equation Y = VA/(K + A), using the computer 
program of Cleland [ 121. 
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some reduction of NAD and NADP by rat brain ex- 
tracts in the absence of either 3-phosphoglycerate or 
DL-glycerate, it was necessary to read these “back- 
ground” velocities over the same time period as the 
velocities with both substrates to estimate the initial 
velocity of the reactions catalysed by the dehydrogen- 
ases. 
Initial velocities have been analysed by the methods 
of Cleland [ 11, 121, and his notation has been used 
for the appropriate equations and the kinetic con- 
stants. 
3. Results 
The initial velocity of the reaction between D- 
glycerate and NADP, as catalysed by the rat cortex 
extracts, appears to be inhibited by glycine. Fig. 1 
shows a double reciprocal plot with DL-glycerate as 
variable substrate at a fixed concentration of NADP 
and at increasing concentrations of glycine. The data 
are fitted to the equation which describes linear non- 
competitive inhibition (see legend to fig. 1). Values 
for the slope inhibition constant (K,), and for the 
intercept inhibition constant (Kti) derived from this 
and similar experiments are given in table 1. The 
dotted lines in fig. 1 indicate the inhibition by serine. 
Inhibition constants derived from this very limited 
data are shown in table 1 for comparison with those 
found for glycine inhibition. 
Measurement of the initial velocity of the reaction 
of 3-phosphoglycerate and NAD as cataiysed by rat 
cortex extracts was more difficult, both because there 
is a reasonable rate of NAD reduction in the absence 
of added 3-phosphoglycerate, and because this “back- 
ground” rate of NAD reduction was considerably in- 
creased by the addition of glycine or serine (fig. 2A). 
When these increased “background” rates are taken 
into account, the initial velocity of the reaction 
catalysed by 3-phosphoglycerate dehydrogenase ap- 
pears to be inhibited slightly by glycine (fig. 2B), and 
perhaps more significantly by serine (fig. 2C). 
The inhibition by glycine with respect to 3-phos- 
phoglycerate has been fitted to the equation for 
linear non-competitive inhibition to yield the con- 
stants listed in table 1. The inhibition by serine, as 
recorded in fig. 2C, is obviously non-linear, although 
insufficient data are present in this preliminary exper- 
iment to define the nature of the inhibition. It 
appears to be competitive. 
4. Discussion 
Because our aim was only to investigate possible 
end-product inhibitions of enzymes which may be in- 
volved in glycine synthesis, we have worked with a 
preparation of rat cortex which is, at best, only 
10-l 5-fold purified over the homogenate. The physi- 
cal and chemical properties of these brain enzymes have 
not yet been described. Therefore, without extensive 
enzyme purification and a study of reaction mechan- 
isms, it is not possible to interpret mechanistically the 
inhibitions recorded here. Nevertheless it seems clear 
that, under the conditions of assay, both D-glycerate 
dehydrogenase and 3-phosphoglycerate dehydrogen- 
ase are inhibited by glycine and serine. 
The inhibitions of 3-phosphoglycerate dehydrogen- 
ase are of interest because the initial velocities of 
animal enzymes so far examined, unlike those from 
E. coli [ 141 and plants [ 15,161, have been found to 
be insensitive to glycine or serine [17, 181. In addi- 
tion, when serine inhibition has been examined by 
measuring the incorporation in vitro of “C-3-phos- 
phoglycerate into phosphoserine and serine in the 
presence and absence of serine, concentrations of 
serine up to 10 mM did not inhibit the incorporation 
catalysed by either mouse brain [ 191 or KB cell [20] 
extracts. Therefore serine did not appear to inhibit 
any enzymes on the pathway to phosphoserine under 
these conditions. However, in a more recent paper 
by Davis and Fallon [21] it was found that 16.6 mM 
serine did reduce incorporation. These results are 
compatible with the initial velocity results of fig. 2C 
where serine inhibition is only readily apparent at 
concentrations over 10 mM. Significant inhibition by 
glycine (fig. 2B and table 1) requires high glycine 
concentrations and so may not be metabolically im- 
portant. 
NAD but not NADP reduction was stimulated by 
the addition of glycine or serine in the absence of 
glycerate or 3-phosphoglycerate (fig. 2A), indicating an 
NAPdependent oxidation of either the amino acids 
or substances formed from them by the rat cortex 
extracts. Reactions which may be occurring are at 
present being investigated. 
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Although the conditions used to measure the 
enzyme activities are not physiological, the relative 
sensitivity of D-glycerate dehydrogenase to glycine 
indicates that this inhibition may be of metabolic 
importance. Although the inhibition constants of 
table 1 are higher than normal glycine concentrations, 
it must be borne in mind that they are only apparent 
constants, that they are almost certainly not simple 
dissociation constants, and that glycine concentrations 
in the central nervous system can be as high as 7 
pmoles/g in the ventral grey part of the cat spinal cord 
[22]. Moreover, the non-competitive nature of the in- 
hibition suggests that glycine is not acting simply as a 
substrate analogue but rather as an allosteric end- 
product inhibitor. The high concentrations of serine 
required to inhibit the enzyme suggest hat serine in- 
hibition may not be of physiological significance. This 
raises the question as to whether glycine formed from 
D-glycerate is made via serine, or whether it could be 
made via the decarboxylation of hydroxypyruvate as 
suggested by Sallach [23] . This possibility is under in 
vestigation. 
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